CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Study of Patients Receiving an Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Sponsor: Investigator initiated study
Enrolling: Male and Female Patients
IRB Number: AAAL0156
U.S. Govt. ID: NCT01966367
Contact: Brian Volonte: (212) 304-7806 / bv2272@cumc.columbia.edu
Additional Study Information: The purpose of this study is to determine the incidence and severity of acute GVHD following CD34+ selection in children, adolescents and young adults receiving an allogeneic peripheral blood stem cell transplant from a family member or unrelated adult donor for a non-malignant condition.
This study is closed
Investigator
Diane George, MD
Do You Qualify?
Is the patient 40 years of age or younger? Yes No
Is the patient a candidate for stem cell transplant for a non-malignant disease? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Brian Volonte
bv2272@cumc.columbia.edu
(212) 304-7806